These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Stem cells therapies for gastrointestinal and liver diseases. Iacob R; Sîrbu-Boeţi P; Iacob S; Dima S; Gheorghe C; Gheorghe L; Popescu I Chirurgia (Bucur); 2009; 104(2):131-40. PubMed ID: 19499655 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic Stem Cell Transplantation in Refractory Crohn's Disease: Should It Be Considered? Reider S; Binder L; Fürst S; Hatzl S; Blesl A Cells; 2022 Nov; 11(21):. PubMed ID: 36359859 [TBL] [Abstract][Full Text] [Related]
7. Complications Following Stem Cell Therapy in Inflammatory Bowel Disease. Wei H; Liu X; Ouyang C; Zhang J; Chen S; Lu F; Chen L Curr Stem Cell Res Ther; 2017; 12(6):471-475. PubMed ID: 28302045 [TBL] [Abstract][Full Text] [Related]
8. Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD-Low Intensity Therapy Evaluation Study Investigators. Pockley AG; Lindsay JO; Foulds GA; Rutella S; Gribben JG; Alexander T; Snowden JA Front Immunol; 2018; 9():646. PubMed ID: 29670622 [TBL] [Abstract][Full Text] [Related]
9. Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBD. Ricart E Dig Dis; 2012; 30(4):387-91. PubMed ID: 22796802 [TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
11. Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. Tack GJ; Wondergem MJ; Al-Toma A; Verbeek WH; Schmittel A; Machado MV; Perri F; Ossenkoppele GJ; Huijgens PC; Schreurs MW; Mulder CJ; Visser OJ Bone Marrow Transplant; 2011 Jun; 46(6):840-6. PubMed ID: 20818442 [TBL] [Abstract][Full Text] [Related]
12. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Al-toma A; Visser OJ; van Roessel HM; von Blomberg BM; Verbeek WH; Scholten PE; Ossenkoppele GJ; Huijgens PC; Mulder CJ Blood; 2007 Mar; 109(5):2243-9. PubMed ID: 17068146 [TBL] [Abstract][Full Text] [Related]
13. High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. Verburg Ro; Toes RE; Fibbe WE; Breedveld FC; van Laar JM Hum Immunol; 2002 Aug; 63(8):627-37. PubMed ID: 12121670 [TBL] [Abstract][Full Text] [Related]
15. Haematopoietic stem cell transplantation: current status. Kumar L Natl Med J India; 2007; 20(3):128-37. PubMed ID: 17867617 [TBL] [Abstract][Full Text] [Related]
16. [Current status of hematopoietic stem cell transplantation for malignant lymphoma]. Ueda S; Okamoto S Nihon Rinsho; 2014 Mar; 72(3):478-82. PubMed ID: 24724407 [TBL] [Abstract][Full Text] [Related]
17. Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases? Hawkey CJ; Hommes DW Gastroenterology; 2017 Feb; 152(2):389-397.e2. PubMed ID: 27845055 [TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies. Kwong YL Bone Marrow Transplant; 2009 Dec; 44(11):709-14. PubMed ID: 19767784 [TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation. Buser AS; Stern M; Bucher C; Arber C; Heim D; Halter J; Meyer-Monard S; Stussi G; Lohri A; Ghielmini M; Tichelli A; Passweg JR; Gratwohl A Bone Marrow Transplant; 2007 Mar; 39(6):335-40. PubMed ID: 17342158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]